UBS AM’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.04M Sell
262,648
-6,841,120
-96% -$79.2M ﹤0.01% 1951
2025
Q1
$62M Buy
7,103,768
+4,987,195
+236% +$43.5M 0.02% 639
2024
Q4
$30.4M Buy
2,116,573
+193,588
+10% +$2.78M 0.01% 796
2024
Q3
$43.4M Sell
1,922,985
-3,498
-0.2% -$79K 0.01% 702
2024
Q2
$37.5M Buy
1,926,483
+1,791,802
+1,330% +$34.9M 0.01% 683
2024
Q1
$5.05M Buy
134,681
+1,717
+1% +$64.4K ﹤0.01% 1245
2023
Q4
$7.44M Sell
132,964
-777
-0.6% -$43.5K ﹤0.01% 1097
2023
Q3
$5.52M Sell
133,741
-300
-0.2% -$12.4K ﹤0.01% 1172
2023
Q2
$7.48M Hold
134,041
﹤0.01% 1073
2023
Q1
$7.48M Buy
134,041
+5,546
+4% +$309K ﹤0.01% 1073
2022
Q4
$4.68M Sell
128,495
-1,018
-0.8% -$37.1K ﹤0.01% 1192
2022
Q3
$3.69M Sell
129,513
-329,829
-72% -$9.39M ﹤0.01% 1307
2022
Q2
$20.8M Sell
459,342
-95,411
-17% -$4.32M 0.01% 729
2022
Q1
$42.2M Buy
554,753
+57,624
+12% +$4.38M 0.02% 654
2021
Q4
$74.1M Sell
497,129
-31,151
-6% -$4.64M 0.03% 552
2021
Q3
$76.9M Buy
528,280
+10,327
+2% +$1.5M 0.03% 509
2021
Q2
$101M Buy
517,953
+20,239
+4% +$3.96M 0.04% 429
2021
Q1
$90.1M Sell
497,714
-123,394
-20% -$22.3M 0.04% 453
2020
Q4
$87.9M Buy
621,108
+180,577
+41% +$25.6M 0.04% 444
2020
Q3
$54.9M Buy
440,531
+45,150
+11% +$5.63M 0.03% 489
2020
Q2
$35.3M Buy
395,381
+32,389
+9% +$2.89M 0.02% 589
2020
Q1
$22.6M Buy
362,992
+505
+0.1% +$31.5K 0.02% 643
2019
Q4
$27.6M Buy
362,487
+177,804
+96% +$13.6M 0.02% 691
2019
Q3
$9.31M Buy
+184,683
New +$9.31M 0.01% 977